Targeting bile‐acid signalling for metabolic diseases
Open accessThe DOI matches its Crossref record; 165 of the 169 references it cites were found in a registry or an index.
Abstract
Bile acids are increasingly being appreciated as complex metabolic integrators and signalling factors and not just as lipid solubilizers and simple regulators of bile-acid homeostasis. It is therefore not surprising that a number of bile-acid-activated signalling pathways have become attractive therapeutic targets for metabolic disorders. Here, we review how the signalling functions of bile acids can be exploited in the development of drugs for obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis, as well as other associated chronic diseases such as non-alcoholic steatohepatitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through FXR activation, OCA modulates bile acid synthesis, absorption, transport, secretion, and metabolism, with a net effect of choleresis.(157,158)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“In animal models, FXR activation has demonstrated antifibrotic and anti-inflammatory properties as well.(157)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“After conjugation with either taurine or glycine, primary bile acids are released into the intestine to assist with lipid digestion and are recycled back into the liver (Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“By activating nuclear farnesoid X receptor (FXR) and plasma membrane TGR5 receptor, bile acids were shown to regulate systemic lipid, cholesterol, and glucose metabolism, as well as energy and immune homeostasis (Calmus and Poupon, 2014;de Aguiar Vallim et al., 2013;Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“In addition, FXR regulates other pathways with direct antiinflammatory and antifibrotic effects. 13-15”
From A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis (2016) · cites this paper as [13]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Research works printed but not linked: 1
- Harnish, D. C. et al. A synthetic farnesoid X receptor (FXR) agonist protects against diet-induced dyslipidemia. J. Clin. Lipidol. 1, 362 (2007).
Cited by
Items 101–200 of 1,002
G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes
Wang, X. X., Edelstein, M. H., Gafter, U., Qiu, L., Luo, Y., Dobrinskikh, E., Lucia, S., Adorini, L., D’Agati, V. D., Levi, J., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121271 · Cited by 213
Nagahashi, M., Takabe, K., Liu, R., Peng, K., Wang, X., Wang, Y., Hait, N. C., Wang, X., Allegood, J. C., Yamada, A., et al. (2015) · Hepatology · doi:10.1002/hep.27592 · Cited by 211
Gao, B., Chi, L., Mahbub, R., Bian, X., Tu, P., Ru, H., & Lu, K. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00401 · Cited by 210
Bile acids and colon cancer: Solving the puzzle with nuclear receptors
Degirolamo, C., Modica, S., Palasciano, G., & Moschetta, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.010 · Cited by 210
Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development
Robichaux, W. G., & Cheng, X. (2018) · Physiological Reviews · doi:10.1152/physrev.00025.2017 · Cited by 208
Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
Hu, H., Lin, A., Kong, M., Yao, X., Yin, M., Xia, H., Ma, J., & Liu, H. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-019-01649-8 · Cited by 208
Interactive relationships between intestinal flora and bile acids
Guo, X., Okpara, E. S., Hu, W., Yan, C., Wang, Y., Liang, Q., Chiang, J. Y. L., & Han, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158343 · Cited by 206
“The alternative pathway is initiated by the steroid 27-hydroxylase and the oxysterol 7α-hydroxylase to mainly synthesize CDCA [32].”
BackgroundMetabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits
Zhao, X., Fritsche, J., Wang, J., Chen, J., Rittig, K., Schmitt-Kopplin, P., Fritsche, A., Häring, H.-U., Schleicher, E. D., Xu, G., et al. (2010) · Metabolomics · doi:10.1007/s11306-010-0203-1 · Cited by 206
“Bile acids have recently evolved from detergents that emulsify nutrient lipids and remove cholesterol from the body to systemic signaling molecules (Thomas et al. 2008) and novel functions of bile acids as metabolic integrators of whole body energy homeostasis that influence glucose and lipid…”
BackgroundThe biosynthesis, signaling, and neurological functions of bile acids
Kiriyama, Y., & Nochi, H. (2019) · Biomolecules · doi:10.3390/biom9060232 · Cited by 204
“TGR5, also known as GPBAR1 or membrane-type receptor for BA (M-BAR), has been identified as a GPCR for BA by two independent groups [111,112].”
BackgroundInfluentialAl-Mashhadi, R. H., Sørensen, C. B., Kragh, P. M., Christoffersen, C., Mortensen, M. B., Tolbod, L. P., Thim, T., Du, Y., Li, J., Liu, Y., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004853 · Cited by 203
Sun, L., Pang, Y., Wang, X., Wu, Q., Liu, H., Liu, B., Liu, G., Ye, M., Kong, W., & Jiang, C. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.004 · Cited by 204
Rizzo, G., Passeri, D., De Franco, F., Ciaccioli, G., Donadio, L., Rizzo, G., Orlandi, S., Sadeghpour, B., Wang, X. X., Jiang, T., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064501 · Cited by 195
“BAs thus represent a source for promising novel drugs to treat liver and metabolic diseases (Thomas et al., 2008b).”
BackgroundSelf-citationJoyce, S. A., Kamil, A., Fleige, L., & Gahan, C. G. M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00171 · Cited by 194
“Bile acids entering the enterohepatic circulation have the potential to directly influence FXR signaling in the liver, a process which influences de novo bile acid synthesis and cholesterol metabolism (103).”
BackgroundBile Acids, Obesity, and the Metabolic Syndrome
Ma, H., & Patti, M. E. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.004 · Cited by 176
“Bile acids and regulation of systemic metabolism FXR and TGR5 signaling mechanisms appear to dominate for BA effects on regulation of glucose, lipid, and energy metabolism [1, 27-30].”
Lyu, M., Wang, Y.-F., Fan, G.-W., Wang, X.-Y., Xu, S.-Y., & Zhu, Y. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02146 · Cited by 192
“…in the control of obesity/T2D related glucose and lipid metabolism, and energy homeostasis by activating the nuclear FXR and the cytoplasmic G protein-coupled membrane receptor 5 (TGR5) which regulate a large number metabolic pathways in the host (Thomas et al., 2008, 2009; Wahlstrom et al., 2016).”
BackgroundJones, M. L., Tomaro-Duchesneau, C., Martoni, C. J., & Prakash, S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.758706 · Cited by 190
“In addition, BSH-active Lactobacillus, using Caco-2 cells, resulted in the upregulation of LXR concomitantly with the elevated expression of ABCG5/G8 heterodimeric transporters, and the promotion of cholesterol efflux, with no noticeable effects on Niemann-Pick C1 Like 1 (NPC1L1) expression [103].”
BackgroundInfluentialHepatic lipid droplet homeostasis and fatty liver disease
Seebacher, F., Zeigerer, A., Kory, N., & Krahmer, N. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.04.011 · Cited by 190
The cross talk between microbiota and the immune system: metabolites take center stage
Shapiro, H., Thaiss, C. A., Levy, M., & Elinav, E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.07.003 · Cited by 189
“Postprandial contraction of the gallbladder empties bile acids into the intestinal lumen [28–30], where microbial enzymes can modify the primary bile acids into secondary bile acids by promoting dehydroxylation, dehydrogenation”
BackgroundLake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D., Reily, M. D., Lu, Z., Lehman-McKeeman, L. D., & Cherrington, N. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.022 · Cited by 189
“The alternative pathway utilizes extrahepatic cholesterol sources with the help of CYP27A1, CYP7B1 and CYP39A1 (Li et al., 2011b; Thomas et al., 2008).”
BackgroundInfluentialWang, X. X., Jiang, T., Shen, Y., Caldas, Y., Miyazaki-Anzai, S., Santamaria, H., Urbanek, C., Solis, N., Scherzer, P., Lewis, L., et al. (2010) · Diabetes · doi:10.2337/db10-0019 · Cited by 186
“However, the increased bile acid concentration in FXR KO mice (13) may lead to activation of the membrane bile acid receptor TGR5, a G-protein coupled receptor (49,50), which may exert compensatory actions in FXR deficiency (51).”
BackgroundSelf-citationOhtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187
“BAs can be recycled 4-12 times per day between hepatocytes in the liver and enterocytes in the intestine; this is called the enterohepatic circulation.(90-94) BAs can act as ligands for nuclear receptors, such as FXR, and Takeda G-protein-coupled receptor 5 (TGR5).”
BackgroundSteinert, R. E., Peterli, R., Keller, S., Meyer‐Gerspach, A. C., Drewe, J., Peters, T., & Beglinger, C. (2013) · Obesity · doi:10.1002/oby.20522 · Cited by 186
“Fifth, we only assessed associations between BA, gut peptides and parameters of glycemic control, however, BA may contribute to other metabolic improvements such as increased lipid oxidation and greater use of fat as energy substrate resulting in weight loss/maintenance in these patients (10,37,38).”
BackgroundJin, M., Pan, T., Cheng, X., Zhu, T. T., Sun, P., Zhou, F., Ding, X., & Zhou, Q. (2019) · Aquaculture · doi:10.1016/j.aquaculture.2019.01.063 · Cited by 184
The bile acid membrane receptor TGR5: a valuable metabolic target
Pols, T. W. H., Noriega, L. G., Nomura, M., Auwerx, J., & Schoonjans, K. (2011) · Digestive Diseases · doi:10.1159/000324126 · Cited by 185
“More recently, BAs are increasingly being appreciated as signaling molecules that inform cells and organs concerning the fasting/feeding state, thereby regulating processes ranging from BA and lipid metabolism to glucose and energy homeostasis [ ,”
BackgroundSelf-citationBile acid signaling in neurodegenerative and neurological disorders
Grant, S. M., & DeMorrow, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175982 · Cited by 185
“Unconjugated pr mary bile acids not passively reabsorbed will in eract with the int stinal bacteria flora present in the colon, creating secondary bile acids deoxycholic acid (DCA) from CA and lithocholic acid (LCA) and UDCA from CDCA for humans [15], with the secondary bile acids of murideoxycholic acid (MDCA) and hy…”
BackgroundWu, A.-L., Coulter, S., Liddle, C., Wong, A., Eastham-Anderson, J., French, D. M., Peterson, A. S., & Sonoda, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017868 · Cited by 185
“Although serum BA composition is influenced by a number of factors including hepatic synthesis and transport in the liver, kidney and intestine [21,22], our finding is consistent with a shift of BA synthesis from the neutral to the alternative (acidic) pathway, bypassing FGF19-suppressed Cyp7a1 and proceeding though C…”
BackgroundPhysiology and Physical Chemistry of Bile Acids
di Gregorio, M. C., Cautela, J., & Galantini, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041780 · Cited by 184
“Further variations of the molecular structure can be observed at C-3 carbon due to hydroxyl, sulfate or glucuronate substituents [1,2].”
BackgroundTargeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
Signalling from the periphery to the brain that regulates energy homeostasis
Kim, K.-S., Seeley, R. J., & Sandoval, D. A. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.8 · Cited by 183
Bile acids: Trying to understand their chemistry and biology with the hope of helping patients #
Hofmann, A. F. (2009) · Hepatology · doi:10.1002/hep.22789 · Cited by 182
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
Harach, T., Pols, T. W. H., Nomura, M., Maida, A., Watanabe, M., Auwerx, J., & Schoonjans, K. (2012) · Scientific Reports · doi:10.1038/srep00430 · Cited by 179
Self-citationWang, X. X., Jiang, T., Shen, Y., Adorini, L., Pruzanski, M., Gonzalez, F. J., Scherzer, P., Lewis, L., Miyazaki-Anzai, S., & Levi, M. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00404.2009 · Cited by 178
“It shows high bioavailability and limited off-target effects (45).”
BackgroundSelf-citationGut microbiota: A new target for T2DM prevention and treatment
Liu, L., Zhang, J., Cheng, Y., Zhu, M., Xiao, Z., Ruan, G., & Wei, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.958218 · Cited by 176
“Furthermore, many researches have shown that the relationship between BAs and microbiome plays a key role in the pathogenesis of metabolic disorders including T2DM (18, 19).”
BackgroundHumbert, L., Maubert, M. A., Wolf, C., Duboc, H., Mahé, M., Farabos, D., Seksik, P., Mallet, J. M., Trugnan, G., Masliah, J., et al. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.05.015 · Cited by 177
Sterol Regulation of Metabolism, Homeostasis, and Development
Wollam, J., & Antebi, A. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-081308-165917 · Cited by 158
Antibiotic effects on gut microbiota and metabolism are host dependent
Fujisaka, S., Ussar, S., Clish, C., Devkota, S., Dreyfuss, J. M., Sakaguchi, M., Soto, M., Konishi, M., Softic, S., Altindis, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86674 · Cited by 166
“Bile acids exert their effects through the nuclear receptor FXR and the G protein–coupled membrane receptor TGR5 (also known as GPBAR1 [G protein–coupled bile acid receptor 1]; M-BAR [membrane-type receptor for bile acids]; or GPR131 [G protein–coupled receptor 131]) (24).”
BackgroundFlatt, B., Martin, R., Wang, T.-L., Mahaney, P., Murphy, B., Gu, X.-H., Foster, P., Li, J., Pircher, P., Petrowski, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8014124 · Cited by 163
Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
Luo, L., Aubrecht, J., Li, D., Warner, R. L., Johnson, K. J., Kenny, J., & Colangelo, J. L. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193824 · Cited by 165
Zhang, J., Ni, Y., Qian, L., Fang, Q., Zheng, T., Zhang, M., Gao, Q., Zhang, Y., Ni, J., Hou, X., et al. (2021) · Advanced Science · doi:10.1002/advs.202100536 · Cited by 163
Ichikawa, R., Takayama, T., Yoneno, K., Kamada, N., Kitazume, M. T., Higuchi, H., Matsuoka, K., Watanabe, M., Itoh, H., Kanai, T., et al. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03554.x · Cited by 161
Profiling of Serum Bile Acids in a Healthy Chinese Population Using UPLC–MS/MS
Xie, G., Wang, Y., Wang, X., Zhao, A., Chen, T., Ni, Y., Wong, L., Zhang, H., Zhang, J., Liu, C., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr500920q · Cited by 160
Cyphert, H. A., Ge, X., Kohan, A. B., Salati, L. M., Zhang, Y., & Hillgartner, F. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375907 · Cited by 161
Ke, X., Walker, A., Haange, S.-B., Lagkouvardos, I., Liu, Y., Schmitt-Kopplin, P., von Bergen, M., Jehmlich, N., He, X., Clavel, T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.012 · Cited by 160
“Recent findings supported the important role of the crosstalk between BAs and gut microbiota in regulating host metabolism [57,63,64].”
BackgroundGut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
Xiao, L., Liu, Q., Luo, M., & Xiong, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.729346 · Cited by 179
“In the human gut, the vast and complex microbial community is composed of approximately 100 trillion organisms of more than 1000 different species (Tierney et al., 2019).”
BackgroundLiu, J., Wei, Y., Jia, W., Can, C., Wang, R., Yang, X., Gu, C., Liu, F., Ji, C., & Ma, D. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102452 · Cited by 173
Marksteiner, J., Blasko, I., Kemmler, G., Koal, T., & Humpel, C. (2018) · Metabolomics · doi:10.1007/s11306-017-1297-5 · Cited by 159
“Bile acids have hormone-like functions and interact with membrane bound G-proteins coupled receptors of various tissues (Chiang 2002; Lefebvre et al. 2009; Thomas et al. 2008).”
BackgroundWang, C., Niederstrasser, H., Douglas, P. M., Lin, R., Jaramillo, J., Li, Y., Oswald, N. W., Zhou, A., McMillan, E. A., Mendiratta, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02332-3 · Cited by 157
Palau-Rodriguez, M., Tulipani, S., Isabel Queipo-Ortuño, M., Urpi-Sarda, M., Tinahones, F. J., & Andres-Lacueva, C. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01151 · Cited by 157
“Finally, recent studies have also shown that BA secretion improves insulin secretion, insulin sensitivity and whole-body glucose homeostasis (reviewed in Thomas et al., 2008), improving liver and pancreatic function in obese mice (Thomas et al., 2009; Tremaroli and Bäckhed, 2012).”
BackgroundTGR5 and Immunometabolism: Insights from Physiology and Pharmacology
Perino, A., & Schoonjans, K. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.002 · Cited by 165
Self-citationSong, P., Zhang, Y., & Klaassen, C. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr177 · Cited by 154
“In regard to the magnitude of hydrophobicity of BAs, the order is UDCA<CA<CDCA<DCA<LCA (Heuman, 1989; Thomas et al., 2008).”
BackgroundInfluentialImpaired Generation of 12-Hydroxylated Bile Acids Links Hepatic Insulin Signaling with Dyslipidemia
Haeusler, R. A., Pratt-Hyatt, M., Welch, C. L., Klaassen, C. D., & Accili, D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.010 · Cited by 153
“Additionally, we treated mice with cholic acid (CA), which is known to reduce TGs (Lefebvre et al., 2009; Watanabe et al., 2004).”
BackgroundInfluentialMetabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer’s Disease
Pan, X., Elliott, C. T., McGuinness, B., Passmore, P., Kehoe, P. G., Hölscher, C., McClean, P. L., Graham, S. F., & Green, B. D. (2017) · Metabolites · doi:10.3390/metabo7020028 · Cited by 153
Zhao, Y., Liu, J., Hao, W., Zhu, H., Liang, N. N., He, Z., Ma, K. Y., & Chen, Z. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04666 · Cited by 164
Jiang, Z., Zhuo, L., He, Y., Fu, Y., Shen, L., Xu, F., Gou, W., Miao, Z., Shuai, M., Liang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30712-x · Cited by 168
The human microbiome and bile acid metabolism: Dysbiosis, dysmetabolism, disease and intervention
Jones, M. L., Martoni, C. J., Ganopolsky, J. G., Labbé, A., & Prakash, S. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.880420 · Cited by 150
“In contrast, VDR and PXR are activated by LCA.”
BackgroundInfluentialBile acids and bariatric surgery
Albaugh, V. L., Banan, B., Ajouz, H., Abumrad, N. N., & Flynn, C. R. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.001 · Cited by 148
Pathophysiological role of host microbiota in the development of obesity
Kobyliak, N., Virchenko, O., & Falalyeyeva, T. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0166-9 · Cited by 149
Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease
Gadaleta, R. M., van Mil, S. W. C., Oldenburg, B., Siersema, P. D., Klomp, L. W. J., & van Erpecum, K. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.006 · Cited by 163
Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling
Yang, Y., Hao, C., Jiao, T., Yang, Z., Li, H., Zhang, Y., Zhang, W., Doherty, M., Sun, C., Yang, T., et al. (2025) · Science · doi:10.1126/science.adt0548 · Cited by 160
Simonen, M., Dali-Youcef, N., Kaminska, D., Venesmaa, S., Käkelä, P., Pääkkönen, M., Hallikainen, M., Kolehmainen, M., Uusitupa, M., Moilanen, L., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0673-5 · Cited by 145
“We suggest that the mechanism behind this interaction is related to differentially activated bile acid regulated pathways, including DIO2 [9].”
BackgroundSelf-citationVitamin D and energy homeostasis—of mice and men
Bouillon, R., Carmeliet, G., Lieben, L., 渡辺, 光., Perino, A., Auwerx, J. H., Schoonjans, K., & Verstuyf, A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.226 · Cited by 158
Self-citationIncreased Bile Acid Synthesis and Impaired Bile Acid Transport in Human Obesity
Haeusler, R. A., Camastra, S., Nannipieri, M., Astiarraga, B., Castro-Perez, J., Xie, D., Wang, L., Chakravarthy, M., & Ferrannini, E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2583 · Cited by 144
Slijepcevic, D., Roscam Abbing, R. L. P., Katafuchi, T., Blank, A., Donkers, J. M., van Hoppe, S., de Waart, D. R., Tolenaars, D., van der Meer, J. H. M., Wildenberg, M., et al. (2017) · Hepatology · doi:10.1002/hep.29251 · Cited by 143
“Bile acids are amphipathic molecules that solubilize lipids in the intestinal tract, and are potent systemic signaling hormones, acting through farnesoid X receptor (FXR) and transmembrane G protein-coupled receptor 5 (TGR5) in various organs.((1)) Bile acids undergo effective (re)uptake from the portal blood, limitin…”
BackgroundBile Acid-Induced Arrhythmia Is Mediated by Muscarinic M2 Receptors in Neonatal Rat Cardiomyocytes
Sheikh Abdul Kadir, S. H., Miragoli, M., Abu-Hayyeh, S., Moshkov, A. V., Xie, Q., Keitel, V., Nikolaev, V. O., Williamson, C., & Gorelik, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009689 · Cited by 144
“There is growing evidence that bile acids are versatile signalling molecules endowed with systemic endocrine functions[13].”
BackgroundRole of bile acids in colon carcinogenesis
Nguyen, T. T., Ung, T. T., Kim, N. H., & Jung, Y. D. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i13.577 · Cited by 143
Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway
Fu, D., Wakabayashi, Y., Lippincott-Schwartz, J., & Arias, I. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018376108 · Cited by 140
“In addition to their traditional function in emulsification of dietary fat (8), recent studies reveal that bile acids function as signalingmolecules (9), which increase calcium mobilization (10) and cellular cAMP (9); translocate and activate protein kinase C (11), nuclear farnesoid X receptor (FXR), and pregnane X re…”
BackgroundMethodYang, T., Shu, T., Liu, G., Mei, H., Zhu, X., Huang, X., Zhang, L., & Jiang, Z. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.05.015 · Cited by 155
“As endogenous substances, serum levels of BAs vary during the day following a rhythm dictated by the ingestion of meals [3].”
InfluentialThe influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis
Phelps, T., Snyder, E., Rodriguez, E., Child, H., & Harvey, P. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0265-3 · Cited by 138
Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
Bourgin, M., Kriaa, A., Mkaouar, H., Mariaule, V., Jablaoui, A., Maguin, E., & Rhimi, M. (2021) · Microorganisms · doi:10.3390/microorganisms9061122 · Cited by 139
“The hydrolysis of the conjugated BAs to deconjugated BAs and subsequent production of the secondary BAs can modulate several functions, including farnesoid X receptor (FXR), small heterodimer partner (SHP), cholesterol 7 alpha-hydroxylase (CYP7A1), liver X receptor (LXR), and ATP-binding cassette transporters G5/G8 he…”
BackgroundEffect of different bile acids on the intestine through enterohepatic circulation based on FXR
Xiang, J., Zhang, Z., Xie, H., Zhang, C., Bai, Y., Cao, H., Che, Q., Guo, J., & Su, Z. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1949095 · Cited by 149
“The hydrophobicity of BA is determined by cytotoxicity.(128) DCA, LCA, CDCA and TCDCA have been individually proven to have cytotoxic and cancer-promoting properties.”
BackgroundA Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes
Han, S., Li, T., Ellis, E., Strom, S., & Chiang, J. Y. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0482 · Cited by 137
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders
Fiorucci, S., Cipriani, S., Baldelli, F., & Mencarelli, A. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.11.001 · Cited by 152
“CREB is a transcription factor that regulates the expression of its target genes by binding to specific DNA sequences called cAMP response element-binding proteins (CREs) contained in the promoter of these genes [3,27,28].”
BackgroundBile acid receptors in non-alcoholic fatty liver disease
Li, Y., Jadhav, K., & Zhang, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.015 · Cited by 136
Chen, J., Li, Y., Tian, Y., Huang, C., Li, D., Zhong, Q., & Ma, X. (2015) · Current Protein & Peptide Science · doi:10.2174/1389203716666150630135720 · Cited by 134
In vitro and in vivo characterization of Clostridium scindens bile acid transformations
Marion, S., Studer, N., Desharnais, L., Menin, L., Escrig, S., Meibom, A., Hapfelmeier, S., & Bernier-Latmani, R. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1549420 · Cited by 133
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease
Suk, K. T., & Kim, D. J. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1569513 · Cited by 147
“Gut microbiota closely engage the expression of these enzymes which include CYP7A1, CYP7B1, and CYP27A1 [112].”
BackgroundSteiner, C., Othman, A., Saely, C. H., Rein, P., Drexel, H., von Eckardstein, A., & Rentsch, K. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025006 · Cited by 132
The profile of bile acids and their sulfate metabolites in human urine and serum
Bathena, S. P., Mukherjee, S., Olivera, M. A., & Alnouti, Y. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.10.019 · Cited by 131
Akkermansia muciniphila protects mice against an emerging tick-borne viral pathogen
Xie, J., Li, H., Zhang, X., Yang, T., Yue, M., Zhang, Y., Chen, S., Cui, N., Yuan, C., Li, J., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-022-01279-6 · Cited by 137
Cholestatic liver (dys)function during sepsis and other critical illnesses
Jenniskens, M., Langouche, L., Vanwijngaerden, Y.-M., Mesotten, D., & Van den Berghe, G. (2016) · Intensive Care Medicine · doi:10.1007/s00134-015-4054-0 · Cited by 129
Rodrigues, R. R., Greer, R. L., Dong, X., DSouza, K. N., Gurung, M., Wu, J. Y., Morgun, A., & Shulzhenko, N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02306 · Cited by 129
“Tissue specific host gene expression is important in many metabolic processes (Thomas et al., 2008; Chiang, 2013) and regulated by gut microbiota (Larsson et al., 2012).”
BackgroundCombined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis
Anakk, S., Watanabe, M., Ochsner, S. A., McKenna, N. J., Finegold, M. J., & Moore, D. D. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42846 · Cited by 129
Understanding bile acid signaling in diabetes: From pathophysiology to therapeutic targets
Ferrell, J. M., & Chiang, J. Y. L. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0043 · Cited by 139
García‐Cañaveras, J. C., Donato, M. T., Castell, J. V., & Lahoz, A. (2011) · Journal of Proteome Research · doi:10.1021/pr200629p · Cited by 139
Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids
Ferrebee, C. B., & Dawson, P. A. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.001 · Cited by 126
“Bile acids are being viewed increasingly as metabolic regulators, and this has opened the door to targeting bile acid-related pathways as potential therapies for nonalcoholic fatty liver disease and other metabolic disorders 2,12,13 .”
BackgroundAlcoholic liver disease: A current molecular and clinical perspective
Ohashi, K., Pimienta, M., & Seki, E. (2018) · Liver Research · doi:10.1016/j.livres.2018.11.002 · Cited by 141
Yepuru, M., Eswaraka, J., Kearbey, J. D., Barrett, C. M., Raghow, S., Veverka, K. A., Miller, D. D., Dalton, J. T., & Narayanan, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.147850 · Cited by 125
Cassol, E., Misra, V., Holman, A., Kamat, A., Morgello, S., & Gabuzda, D. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-203 · Cited by 126
“Under physiological conditions, bile acids play an important role in lipid absorption and homeostasis (reviewed in [48]).”
BackgroundGrau, K. R., Zhu, S., Peterson, S. T., Helm, E. W., Philip, D. T., Phillips, M. B., Hernandez, A., Turula, H., Frasse, P., Graziano, V. R., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0602-7 · Cited by 135
Kim, Y., & Rajagopalan, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015456 · Cited by 125
Triglycerides and gallstone formation
Smelt, A. H. M. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.003 · Cited by 129
Perspective: TGR5 (Gpbar-1) in liver physiology and disease
Keitel, V., & Häussinger, D. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.03.008 · Cited by 130
Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease
Xie, C., Huang, W., Young, R. L., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2021) · Nutrients · doi:10.3390/nu13041104 · Cited by 131
“acids such as deoxycholic acid (DCA), lithocholic acid (LCA), and ursodeoxycholic acid (UDCA, a secondary bile acid in humans, but a primary bile acid in rodents), and absorbed passively into the circulation or excreted in the feces [2] (Figure 1).”
BackgroundMetabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations
Leoni, V., Strittmatter, L., Zorzi, G., Zibordi, F., Dusi, S., Garavaglia, B., Venco, P., Caccia, C., Souza, A. L., Deik, A., et al. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.12.005 · Cited by 124
EDP-305 in patients with NASH: a phase II double-blind placebo-controlled dose-ranging study
Ratziu, V., Rinella, M. E., Neuschwander-Tetri, B. A., Lawitz, E., Denham, D., Kayali, Z., Sheikh, A., Kowdley, K. V., Desta, T., Elkhashab, M., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.018 · Cited by 123
Bile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 131
Tiwari, A., & Maiti, P. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.005 · Cited by 122
The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia
Okin, D., & Medzhitov, R. (2016) · Cell · doi:10.1016/j.cell.2016.02.023 · Cited by 121
Role of bile acids in inflammatory liver diseases
Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00869-6 · Cited by 121
Bertaggia, E., Jensen, K. K., Castro-Perez, J., Xu, Y., Di Paolo, G., Chan, R. B., Wang, L., & Haeusler, R. A. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2016 · Cited by 118
“They are well known for their role as surfactants, and this function is fundamental for the absorption of lipids and liposoluble vitamins upon the ingestion of a meal (8, 10, 34).”
Background
Metadata
- Authors
- Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K.
- Affiliations
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- University of Perugia (IT)
- Intercept Pharmaceuticals (United States) (US)
- Corresponding author
- Auwerx, Johan
- Schoonjans, Kristina
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-08
- Volume
- 7
- Issue
- 8
- Pages
- 678-693
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2078810890
- Cited by
- 1,422
- References
- 169
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 106 · 2023: 107 · 2022: 113 · 2021: 90 · 2020: 83 · 2019: 82 · 2018: 78 · 2017: 81 · 2016: 75 · 2015: 75 · 2014: 71 · 2013: 77 · 2012: 47
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- European Commission
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Société Française de Nutrition
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- bile acids, bile acid signaling, metabolic disorders, obesity, type 2 diabetes, hypertriglyceridemia, atherosclerosis, nonalcoholic steatohepatitis, therapeutic target, drug development
- MeSH terms
- Animals, Bile Acids and Salts, Humans, Metabolic Diseases, Signal Transduction, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.